Throne: Smart Toilet Startup Secures $4 Million in Seed Funding

Austin-based health tech startup Throne has successfully raised $4 million in seed funding to revolutionize gut health monitoring. The round was led by Moxxie Ventures' founder Katie Jacobs Stanton, with participation from a diverse group of investors including notable angel investors such as Lance Armstrong, Tara Viswanathan (Rupa Health co-founder), and Justin Mares (TrueMed founder). Other investors include Accomplice, Long Journey Ventures, V1.VC, Night Capital, Retron VC, and Myelin Ventures. This significant investment underscores the growing interest in innovative healthcare solutions leveraging AI and smart home technology.

Throne's innovative device, which mounts onto existing toilet bowls, utilizes computer vision and AI to analyze waste and provide insights into various health conditions, including irritable bowel syndrome (IBS), ulcerative colitis, and even indicators of certain cancers. The company plans to use the funding to finalize product development, accelerate its path to market (with a planned launch in January 2026), and expand its team. The addition of John Capodilupo, former CTO of WHOOP, as Chief Product Officer further strengthens Throne's capabilities in bringing this unique product to consumers.

The company's journey to securing this funding is as remarkable as its technology. Born from a casual poker game conversation, Throne's concept quickly gained traction, fueled by a series of serendipitous events and introductions within the healthcare and investment communities. These connections proved crucial in securing partnerships with researchers at the University of Washington and the University of Chicago, validating the technology's potential and bolstering investor confidence.

Throne's success highlights the potential for innovative, AI-driven solutions to improve healthcare accessibility and early detection of chronic conditions. With its impressive funding round and strong team, the company is well-positioned to disrupt the market and bring its unique approach to gut health monitoring to a wider audience.